Covered recipient · General Payments record
DANE D SIMONS
Allopathic & Osteopathic Physicians General Practice
General Payments · PY2018–2024
$3,342.14
- Reported across 195 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $461.75 | 31 |
| Education | $16.90 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $185.81 | 17 |
| Lilly USA, LLC | $91.92 | 5 |
| ITI, Inc. | $56.71 | 3 |
| Corium, Inc. | $54.52 | 3 |
| Acerta Pharma LLC | $36.76 | 2 |
| PFIZER INC. | $35.70 | 2 |
| Novo Nordisk AS | $17.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.48 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106106791 | CMS |
| ABBVIE INC. | $8.19 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106106793 | CMS |
| ABBVIE INC. | $8.45 | 03/04/2024 | Education | Undisputed | 01/23/2026 | 1106106795 | CMS |
| ABBVIE INC. | $32.57 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106106797 | CMS |
| ABBVIE INC. | $8.42 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106106799 | CMS |
| ABBVIE INC. | $19.21 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106106801 | CMS |
| ABBVIE INC. | $7.43 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106106803 | CMS |
| ABBVIE INC. | $7.35 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106106805 | CMS |
| ABBVIE INC. | $6.86 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106106807 | CMS |
| ABBVIE INC. | $9.43 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106106809 | CMS |
| ABBVIE INC. | $7.05 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106106811 | CMS |
| ABBVIE INC. | $6.74 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106106813 | CMS |
| ABBVIE INC. | $8.17 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106106815 | CMS |
| ABBVIE INC. | $7.49 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106106817 | CMS |
| ABBVIE INC. | $10.71 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106106819 | CMS |
| ABBVIE INC. | $7.81 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106106821 | CMS |
| ABBVIE INC. | $8.45 | 12/06/2024 | Education | Undisputed | 01/23/2026 | 1106106823 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.01 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104452060 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.75 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104497516 | CMS |
| Corium, LLC | $28.76 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100198770 | CMS |
| Corium, LLC | $19.46 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100176172 | CMS |
| Corium, LLC | $6.30 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100147589 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15.64 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143321003 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20.11 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143321007 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20.96 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143321011 | CMS |
| Lilly USA, LLC | $19.41 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136116074 | CMS |
| Lilly USA, LLC | $18.72 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136130382 | CMS |
| Lilly USA, LLC | $18.72 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136124867 | CMS |
| Lilly USA, LLC | $15.10 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136140109 | CMS |
| Lilly USA, LLC | $19.97 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136114116 | CMS |
| Novo Nordisk Inc | $17.23 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097137087 | CMS |
| PFIZER INC. | $17.75 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131989939 | CMS |
| PFIZER INC. | $17.95 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131117757 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.